Average Target Price for Japan Tobacco Increases 7.54%

Market by 2FIRSTS.ai

Dec.18.2023

Average Target Price for Japan Tobacco Increases 7.54%

The average target price for Japan Tobacco has been revised to $23.43, a 7.54% increase since August 1.

According to investment platform Fintel, recent reports have shown that the average one-year target price for Japan Tobacco (OTC:JAPAF) has been revised to $23.43 per share, representing a 7.54% increase from the valuation of $21.78 per share on August 1, 2023.

The target price is the average forecast provided by numerous analysts. The latest target price range is from a low of $15.69 per share to a high of $28.92 per share. This average target price represents a decrease of 7.33% from the recent closing price of $25.28 per share.

Furthermore, 334 funds or institutions were reported to hold shares of Japan Tobacco, a decrease of 5 or 1.47% from the previous quarter. The average holding ratio of all funds investing in Japan Tobacco was 0.37%, a decrease of 0.21% compared to the previous quarter. The total number of shares held by institutions increased by 0.95% in the past three months to reach 108,634K shares.

References:

[1] Japan Tobacco (JAPAF) Price Target Increased by 7.54% to 23.43

Also Read:

[1] Japan Tobacco Inc. Stock Price Declines by 0.9% on December 5th

[2] Japan Tobacco Inc's Stocks Soar by 4.1% in Trading

[3] Japan Tobacco Inc.: Stock Price Dropped 0.9% in Tuesday's Trading

#Traditional tobacco #Asia #Market #Japan

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Belgian Drug Commissioner Warns of Hidden Opioids in Illegal Vapes

Belgium’s drug commissioner Ine Van Wymersch has warned that more than 80% of illegal refillable vape capsules seized in Belgium contain synthetic opioids, posing serious risks of early addiction among children. She told Euronews that these substances, which have no distinctive smell or color, could lead to opioid dependence from a young age.

Dec.08 by 2FIRSTS.ai

EUIPO Rejects Imiracle’s Opposition to ‘Crystal’ Trademark, Citing Lack of Proof of Actual Use in Slovakia

The EUIPO has ruled that Imiracle failed to demonstrate actual commercial use of its “Elfbar Crystal” brand in Slovakia, and therefore rejected in full the company’s opposition to Shenzhen SKE Technology’s application to register the “Crystal” trademark. The EUIPO noted that the sales records submitted by Imiracle were limited in scope and that the product packaging was in Ukrainian, which it found insufficient to prove that the products had been placed on the Slovak market.

Dec.10 by 2FIRSTS.ai

Product | INNOKIN Launches Magnetic Open-System Device, Pod + Power Bank Design Debuts in UK and US Channels

INNOKIN has recently launched its new open-system e-cigarette, EZ LEVA, on its official website, and it is now available through online channels in the UK and the United States. Featuring a magnetic design, the device adopts a pod + power bank form factor. Its 400mAh (device) + 2000mAh (charging case) battery setup follows a similar configuration logic to comparable products such as the SMOK Airmate and KIWI 2.

Dec.09 by 2FIRSTS.ai

NZ Issues National High Alert on Etomidate-Laced Vapes After Hospitalisations

New Zealand’s High Alert drug harm monitoring system has issued a public High Alert warning after multiple hospitalisations linked to illicit vape pods containing the anaesthetic etomidate. Known on the street as space oil, k-pods, or eto, these vapes were first detected in January 2025. Customs has since seized additional samples, and clinics nationwide report rising cases of poisoning and hypoglycaemia.